Colony »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Colony

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Colony from 13F filings

Historical chart of Colony investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Colony consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Colony

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.0M 2.3M 1.32

More positions owned by Colony

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Select Sector Spdr Tr State Street Tec (XLK)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Valued Advisers Tr Kovitz Core Eqt (EQTY)
Vanguard World Inf Tech Etf (VGT)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p Ttl Stk (ITOT)

View all positions for Colony

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
Point72 Asset Management
LMR Partners
Balyasny Asset Management
Alberta Investment Management Corporation
Jain Global
Jpmorgan Chase & Co
Lazard Asset Management
Lombard Odier Asset Management
Absolute Investment Advisers
Citadel Advisors
Linden Advisors
Calamos Advisors
Tenor Capital Management
Wells Fargo & Company

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1